Evicenter
Ocrevus (ocrelizumab) in Multiple sclerosis
Manufacturer
Genentech, Inc.
Questions
60
Last updated

All questions

Safety: Ocrevus (ocrelizumab) in multiple sclerosis

17 questions · 7 sources

Monitoring

What tests are needed before starting Ocrevus or Ocrevus Zunovo?

How long are patients monitored after an Ocrevus or Ocrevus Zunovo dose?

Side effects

How common are infusion reactions with Ocrevus IV?

Applies to Relapsing forms of multiple sclerosis and primary progressive multiple sclerosis in adults (OCREVUS intravenous)

Note: The rates are from Tables 4 (RMS, OPERA I and II) and 5 (PPMS, ORATORIO) of the OCREVUS Prescribing Information. REBIF-treated patients received placebo infusions every 24 weeks, and the PPMS comparator was placebo infusions.

How common are injection reactions with Ocrevus Zunovo?

Applies to Relapsing forms of multiple sclerosis and primary progressive multiple sclerosis in adults (OCREVUS ZUNOVO subcutaneous)

Note: Study 4 of the OCREVUS ZUNOVO Prescribing Information is OCARINA II, an open-label trial.

How are Ocrevus infusion reactions and Ocrevus Zunovo injection reactions managed?

What are the most common side effects of Ocrevus?

Applies to Relapsing forms of multiple sclerosis and primary progressive multiple sclerosis in adults (OCREVUS intravenous)

Note: The rates are from Tables 4 (RMS, OPERA I and II, OCREVUS vs REBIF) and 5 (PPMS, ORATORIO, OCREVUS vs placebo) of the OCREVUS Prescribing Information, which list adverse reactions with an incidence of at least 5% for OCREVUS and higher than the comparator.

Do people develop antibodies against Ocrevus?

Applies to Relapsing forms of multiple sclerosis and primary progressive multiple sclerosis in adults (OCREVUS intravenous)

Note: Studies 1, 2, and 3 of the OCREVUS Prescribing Information are OPERA I, OPERA II, and ORATORIO.

Warnings

Does Ocrevus increase the risk of infections?

Note: The all-exposure population includes patients from the controlled trials, their open-label extensions, and other ocrelizumab studies.

Does Ocrevus increase the risk of herpes or shingles?

Is hepatitis B screening required before Ocrevus or Ocrevus Zunovo?

Can Ocrevus cause progressive multifocal leukoencephalopathy (PML)?

“Cases of progressive multifocal leukoencephalopathy (PML) have been reported in patients with MS treated with ocrelizumab in the postmarketing setting. PML is an opportunistic viral infection of the brain caused by the JC virus (JCV) that typically occurs only in patients who are immunocompromised, and that usually leads to death or severe disability. PML has occurred in ocrelizumab-treated patients who had not been treated previously with natalizumab, (which has a known association with PML), were not taking any immunosuppressive or immunomodulatory medications associated with risk of PML prior to or concomitantly with ocrelizumab and did not have any known ongoing systemic medical conditions resulting in compromised immune system function. JCV infection resulting in PML has also been observed in patients treated with other anti-CD20 antibodies and other MS therapies. At the first sign or symptom suggestive of PML, withhold treatment with ocrelizumab-containing products and perform an appropriate diagnostic evaluation. Typical symptoms associated with PML are diverse, progress over days to weeks, and include progressive weakness on one side of the body or clumsiness of limbs, disturbance of vision, and changes in thinking, memory, and orientation leading to confusion and personality changes. Magnetic resonance imaging (MRI) findings may be apparent before clinical signs or symptoms of PML. Monitoring with MRI for signs consistent with PML may be useful, and any suspicious findings should lead to further investigation to allow for an early diagnosis of PML, if present. If PML is confirmed, treatment with ocrelizumab should be discontinued.” (opens the source at this quote in a new tab)

Does Ocrevus lower immunoglobulin (IgG) levels?

Does Ocrevus increase the risk of cancer, including breast cancer?

Note: The all-exposure population includes patients from the controlled trials, their open-label extensions, and other ocrelizumab studies.

Can people taking Ocrevus get vaccines, including live vaccines?

Can Ocrevus cause colitis?

Can Ocrevus cause liver damage?

Who should not take Ocrevus (contraindications)?